Mark N. Lampert, 10% Owner at CTI BIOPHARMA CORP (CTIC), bought 6,333,333 shares at $3.00 ($19.0M) on 2018-02-09, disclosed to the SEC on 2018-02-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.00 | 483,708 | $1.5M | 7.6% |
| 2 | $3.00 | 699,225 | $2.1M | 11.0% |
| 3 | $3.00 | 2,109,280 | $6.3M | 33.3% |
| 4 | $3.00 | 3,041,120 | $9.1M | 48.0% |
| Total | $3.00 avg | 6,333,333 | $19.0M | 100% |
| Filing → |
| MRUS | BUY | 2021-03-18 | $5.8M | — | Filing → |
| XOMA | BUY | 2019-12-20 | $8.2M | — | Filing → |
| CALA | BUY | 2019-11-22 | $1.5M | — | Filing → |